Gaviscon Double Action, peppermint suspension 300 ml

This drug is a combination of alginate and antacids (calcium carbonate and sodium hydrocarbonate).

Pharmacodynamics

When taken orally the active ingredients of the drug Gaviscon® Dual Action quickly react with acidic contents of the stomach. This produces alginate gel with a pH value close to neutral.

Within three minutes the gel forms a protective barrier on the surface of the stomach contents preventing the occurrence of gastroesophageal reflux (backflow of stomach contents into the esophagus) for up to four hours.

In severe cases of reflux (regurgitation), the gel enters the esophagus ahead of the rest of the stomach contents, where it reduces irritation of the esophageal mucosa. Calcium carbonate quickly neutralizes the hydrochloric acid of gastric juice, relieving the sensation of heartburn.

This effect is enhanced by the presence in the drug of sodium bicarbonate, which also has a neutralizing effect. Total acid neutralizing activity of the drug in the minimum dose of 10 ml is approximately 10 mEq.

Pharmacokinetics

The mechanism of action of the drug Gaviscon® Dual Action is physical and does not depend on absorption into the systemic bloodstream.

Indications

Active ingredient

Composition

How to take, the dosage

Ingestion.

Adults and children over 12 years of age: 10 – 20 ml after meals and before going to bed (up to 4 times a day).

The maximum daily dose is 80 ml.

There is no need to change the dose for elderly patients.

The drug should not be used for prolonged periods; if symptoms persist after 7 days of taking the drug, a physician should be consulted to revise the therapy.

Interaction

Special Instructions

Contraindications

With caution:

Side effects

Evaluation of the incidence of adverse reactions is based on the following criteria: very common (≥ 1/10), common (≥ 1/100, < 1/10), infrequent (≥ 1/1000, < 1/100), rare (≥ 1/10000, < 1/1000), very rare (< 1/10000) and of unknown frequency (frequency cannot be calculated from available data).

Immune system disorders: unspecified frequency – anaphylactic and anaphylactoid reactions, hypersensitivity reactions (urticaria).

Respiratory system, chest and mediastinum disorders: unspecified frequency – respiratory effects (bronchospasm).

The administration of large amounts of calcium carbonate may cause alkalosis, hypercalcemia, acid ricochet condition, lactic-alkaline syndrome, constipation. These conditions usually occur in overdose.

Overdose

Symptoms: bloating may occur.

Similarities